Non-Invasive Screening for Fetal Aneuploidy

Completed

Conditions studied: Down Syndrome, Edwards Syndrome

In brief

The purpose of this study is to determine if a laboratory test developed by the Sequenom Center for Molecular Medicine (SCMM) that uses a new marker found in the mother's blood can better identify pregnancies that have a child with a chromosome abnormality such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), or other chromosome abnormality.

Key facts

Study ID
NCT00847990
Run by
Sequenom, Inc.
People needed
5000
Starts
2009-03-01
Expected to finish
2011-08-01
Last updated by the study team
2011-09-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.